// App-Quantinova.ai

: Outcomes of patients (pts) with metastatic colorectal cancer (mCRC) participating in phase I clinical trials: The Sarah Cannon Research Institute UK experience.

Researchers

Presenter

  • Ekaterina Ignatova

Principal Investigators

  • Elisa Fontana

  • Siyun Luo

  • Anja Williams

  • Hendrik-Tobias Arkenau

Medical Centers

  • Sarah Cannon Research Institute, London, United Kingdom

  • Sarah Cannon Research Institute, London, United Kingdom

  • Kings College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Tipiracil and trifluridine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved